000 | 01068 a2200301 4500 | ||
---|---|---|---|
005 | 20250513093458.0 | ||
264 | 0 | _c19960916 | |
008 | 199609s 0 0 spa d | ||
022 | _a0213-005X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlarcón, T | |
245 | 0 | 0 |
_a[Mechanism of action and resistance to fluoroquinolones]. _h[electronic resource] |
260 |
_bEnfermedades infecciosas y microbiologia clinica _cFeb 1996 |
||
300 |
_a111-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-Infective Agents _xmetabolism |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 | _aCell Membrane Permeability |
650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xchemistry |
650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
650 | 0 | 4 | _aFluoroquinolones |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTopoisomerase II Inhibitors |
700 | 1 | _aLópez-Brea, M | |
773 | 0 |
_tEnfermedades infecciosas y microbiologia clinica _gvol. 14 _gno. 2 _gp. 111-7 |
|
999 |
_c8711363 _d8711363 |